Search
for
Sort by
Research 181–210 of 1000+
- Unusual presentation with polymenorrhagia and markedly high 17-hydroxy progesterone levels in a lady with Non-Classic Congenital Adrenal Hyperplasia.
- Genetics and Epigenetics of Polycystic Ovary Syndrome
- Delayed Puberty
- Androgen Action in the Ovary
- Transient Ca2+ entry by plasmalogen-mediated activation of receptor potential cation channel promotes AMPK activity
- Female pattern hair loss: current treatment concepts.
- Angiogenin is expressed in human dermal papilla cells and stimulates hair growth
- Postmenopausal Alopecia due to Ovarian Hyperandrogenemia Treated with Bilateral Salpingo-oophorectomy
- Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
- Diagnosis and Management of Infertility due to Anovulation
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes
- Kisspeptin and LH pulsatile temporal coupling in PCOS patients
- Suety and Spreading-Stromal Hyperplasia and Hyperthecosis Ovary
- Facial hypertrichosis after isotretinoin therapy: Is it a side effect or coincidence?
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Polycystic ovary syndrome and impact on health
- Hirsutism in the Adolescent Female
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation
- A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
- Polycystic Ovary Syndrome
- Hair Loss in Women
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Changes of androgens levels in menopausal women
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients